Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2024
A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
Robert W Lentz, Tyler J Friedrich, Patrick J Blatchford, et al.
Nature Communications
|
May 15, 2024
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials
Neil H Segal, Ignacio Melero, Victor Moreno, et al.
The New England Journal of Medicine
|
March 25, 2026
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer
Frank A Sinicrope, Fang-Shu Ou, Dirk Arnold, et al.
Cancer Research Communications
|
October 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer
Robert W Lentz, Julie Lang, Todd M Pitts, et al.
JCO Precision Oncology
|
March 6, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group
Lakshmi Rajdev, Gentry G King, Christopher H Lieu, et al.
Cancer Immunology Research
|
October 18, 2017
A Blueprint to Advance Colorectal Cancer Immunotherapies
Dung T Le, Vanessa M Hubbard-Lucey, Michael A Morse, et al.
Frontiers in Immunology
|
April 15, 2021
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes
Juan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 25, 2018
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group
Kaitlyn K H Goey, Halfdan Sørbye, Bengt Glimelius, et al.
Nature Reviews. Clinical Oncology
|
July 8, 2020
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper
Arvind Dasari, Van K Morris, Carmen J Allegra, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2024
A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
Robert W Lentz, Tyler J Friedrich, Patrick J Blatchford, et al.
Nature Communications
|
May 15, 2024
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials
Neil H Segal, Ignacio Melero, Victor Moreno, et al.
The New England Journal of Medicine
|
March 25, 2026
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer
Frank A Sinicrope, Fang-Shu Ou, Dirk Arnold, et al.
Cancer Research Communications
|
October 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer
Robert W Lentz, Julie Lang, Todd M Pitts, et al.
JCO Precision Oncology
|
March 6, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group
Lakshmi Rajdev, Gentry G King, Christopher H Lieu, et al.
Cancer Immunology Research
|
October 18, 2017
A Blueprint to Advance Colorectal Cancer Immunotherapies
Dung T Le, Vanessa M Hubbard-Lucey, Michael A Morse, et al.
Frontiers in Immunology
|
April 15, 2021
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes
Juan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 25, 2018
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group
Kaitlyn K H Goey, Halfdan Sørbye, Bengt Glimelius, et al.
Nature Reviews. Clinical Oncology
|
July 8, 2020
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper
Arvind Dasari, Van K Morris, Carmen J Allegra, et al.
Page
of 7